Advances in treatment of mesothelioma
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1080/14656566.2016.1176145
Reference90 articles.
1. Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales
2. Germline BAP1 mutations predispose to malignant mesothelioma
3. Molecular pathogenesis of malignant mesothelioma
4. The Worldwide Pandemic of Asbestos-Related Diseases
5. A Randomized Controlled Trial of Postthoracotomy Pulmonary Rehabilitation in Patients with Resectable Lung Cancer
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma;Pathology - Research and Practice;2023-12
2. Fluorescence in situ hybridization detection of chromosome 22 monosomy in pleural effusion cytology for the diagnosis of mesothelioma;Cancer Cytopathology;2021-01-25
3. Loco-Regional Treatment with Surgical Intervention in Mesothelioma: What Is the Role of Enhancing Local Control Approaches?;Malignant Pleural Mesothelioma;2021
4. Genomic‐based ancillary assays offer improved diagnostic yield of effusion cytology with potential challenges in malignant pleural mesothelioma;Pathology International;2020-06-15
5. Patient experiences of participation in a radical thoracic surgical trial: findings from the Mesothelioma and Radical Surgery Trial 2 (MARS 2);Trials;2019-10-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3